If you or a loved one has been diagnosed with EGFR positive, metastatic non-small cell lung cancer (NSCLC), you’re already facing a lot of decisions. These may include what type of treatment will work best for you. You and your doctor can work ...
In the time since IMBRUVICA® (ibrutinib) was first approved by the FDA in 2013 it has undergone many changes. This includes multiple indication expansions to various types of leukemia and lymphoma, approval as a first-line therapy, and even ...
In today’s oncology landscape, new oral chemotherapy medications or updated indications are being released at an increasing rate. With each approval comes new hope for individuals and their families for a road to remission, and also a ...
The American Cancer Society recognizes February as National Cancer Prevention Month. In honor of this month, we are sharing three ways you and your family can help reduce your risk of cancer or detect cancer earlier. Let's start with the simple ...
Since 1970, the American Red Cross has recognized January as National Blood Donor Month. According to the Red Cross, blood donation drops during the winter because weather often restricts the ability to host a blood drive, or potential donors are ...
Did you know that breast cancer in women is the second most common type of cancer in the US? The National Cancer Institute estimates that 232,670 American women were diagnosed with breast cancer and 40,000 died from the disease in 2014. We are ...
If you or a family member has recently been diagnosed with cancer, or is going through cancer treatment, we understand what a difficult time this is. We also know there are many resources out there to help you understand treatment options and offer ...
The Food and Drug Administration's new streamlined drug approval process allow patients faster access to potentially life-saving drugs. According to recent reports from the Pharmaceutical Research and Manufacturers of America (PhRMA), pharmaceutical ...
Avella is your pharmacy partner for oncology medications, Mekinist and Tafinlar, which are now approved for combination therapy. The United States Food and Drug Administration recently approved Mekinist, in combination with Tafinlar, to treat ...
On March 17th, the Avella of Austin team had the privledge of participating in the Head for the Cure 5K. Our pharmacy team and account managers enjoyed a day outdoors participating in a fun event for a great cause. Head for the Cure 5K events are ...
